| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 09/16/2009 | EP2099755A2 Acetylene derivatives as stearoyl coa desaturase inhibitors |
| 09/16/2009 | EP1960371B1 Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1478364B1 Selective antibacterial agents |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1411046B1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 09/16/2009 | CN101535280A Arylsulfonamide compounds |
| 09/16/2009 | CN101535279A Quinazoline based EGFR inhibitors containing a zinc binding moiety |
| 09/16/2009 | CN101535278A Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoro-methyl)-1-(2h)-pyrimidinyl]-4-fluoro-n-[[methyl-(1-methylethyl)-amino]sulphonyl]benzamide |
| 09/16/2009 | CN101535277A Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2h)-pyrimidinyl]-4-fluoro-n-[[methyl-(1-methyl-ethyl)amino]sulphonyl]benzamide |
| 09/16/2009 | CN101535276A Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors |
| 09/16/2009 | CN101531639A Method for iodinating 5th position of ferric inorganic salt catalyzed 2-pyrimidone and derivatives thereof |
| 09/16/2009 | CN101531638A Compound used as a regulator of estrogen-related receptor and applications thereof |
| 09/16/2009 | CN101531565A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/16/2009 | CN100540547C Inhibitors of histone deacetylase |
| 09/16/2009 | CN100540539C Process for producing 6, 7-bis (2-methoxyethoxy)-quinazolin-4-one |
| 09/16/2009 | CN100540534C N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589105 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound |
| 09/15/2009 | US7589098 Controlling cell proliferation; side effect reduction ; anticancer agenst |
| 09/15/2009 | US7589095 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589090 Urinary tract infections, incontinence; analgesics; bladder diseases; antiinflammatory agents; premenstrual tension; irritable bowel syndrome; chronic obstructive pulmonary disease; respiratory system disorders; gastrointestinal disorders |
| 09/15/2009 | US7589088 Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods |
| 09/15/2009 | US7589077 such as 5-iodo-O6-5'-cyclo-5,6-dihydro-3'-azido-3'-deoxythymidine for prophylaxis or diagnosis of viral diseases caused by hepatitis virus, herpes viruses such as Epstein-Barr virus |
| 09/15/2009 | CA2504399C Process for the preparation of arylamides of heteroaromatic carboxylic acids |
| 09/15/2009 | CA2407754C Prodrugs of hiv replication inhibiting pyrimidines |
| 09/15/2009 | CA2406562C Hiv replication inhibiting pyrimidines and triazines |
| 09/15/2009 | CA2402390C Process for the preparation of pyrimidone derivatives with antifungal activity |
| 09/15/2009 | CA2400155C A novel crystalline form of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid and process therefor |
| 09/15/2009 | CA2362363C Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 09/15/2009 | CA2218561C Compounds and methods of use to treat infectious diseases |
| 09/11/2009 | WO2009037473A3 Nucleobase characterisation |
| 09/11/2009 | WO2007104442A3 Process for the manufacture of a precursor of vitamin b1 |
| 09/11/2009 | CA2715835A1 Amide compounds, compositions and uses thereof |
| 09/10/2009 | US20090227790 A kit for treating a disorder characterized by loss of dopaminergic and/or motoneurons, for treating Parkinson's disease, amyotrophic lateral sclerosis (ALS), or limiting damage to neuronal cells by Parkinsonian conditions |
| 09/10/2009 | US20090227612 Aminopyrimidine Derivatives Inhibiting Protein Kinase Activity, Method For The Preparation Thereof And Pharmaceutical Composition Containing Same |
| 09/10/2009 | US20090227609 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 09/10/2009 | US20090227604 Vitamin d receptor modulators |
| 09/10/2009 | US20090227603 Leukotriene b4 inhibitors |
| 09/10/2009 | US20090227596 Heteroaryl nitrile derivatives |
| 09/10/2009 | US20090227592 Compounds effecting glucokinase |
| 09/10/2009 | US20090227591 Cyclopentene compounds |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090226377 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| 09/09/2009 | EP2097406A1 Hydantoin derivatives used as mmp inhibitors |
| 09/09/2009 | EP2097391A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 09/09/2009 | EP2097390A1 Amino quinazolines derivatives wuth blood platelet reducing properties |
| 09/09/2009 | EP2097382A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
| 09/09/2009 | EP2097378A1 Novel seh inhibitors and their use |
| 09/09/2009 | EP1687857B1 Organic electroluminescent element |
| 09/09/2009 | EP1305296B1 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| 09/09/2009 | CN101528715A 2-phenyl-6-aminocarbonyl-pyrimidine derivatives |
| 09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
| 09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
| 09/08/2009 | US7585975 A group is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to three independent R3 groups. The invention also includes methods of using these compounds as type I receptor tyrosine kinase inhibitors and hyperproliferation diseases |
| 09/08/2009 | US7585870 improved ability to inhibit the replication of mutant strains of drug or multidrug resistant HIV strains; Indene/benzofuran Substituted Pyrimidines |
| 09/08/2009 | US7585869 novel bicyclic derivatives that are useful in the treatment of abnormal cell growth, such as cancer; tyrosine kinase inhibitors |
| 09/08/2009 | CA2546894C Reference standard for characterization of rosuvastatin |
| 09/08/2009 | CA2463598C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| 09/08/2009 | CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia |
| 09/03/2009 | WO2009108657A2 Heteroaryl derivatives as cftr modulators |
| 09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | WO2009058937A3 Heteroaryl ethers and processes for their preparation |
| 09/03/2009 | US20090221822 Process for the Preparation of Dihydroquinazolines |
| 09/03/2009 | US20090221820 Ligands for Transition-Metal-Catalyzed Cross-Couplings, and Methods of Use Thereof |
| 09/03/2009 | US20090221614 Selective serine/threonine kinase inhibitors |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221579 Substituted Amino-Compounds and Uses Thereof |
| 09/03/2009 | US20090221555 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS |
| 09/03/2009 | US20090221551 Substituted fused[1,2] imidazo[4,5c] ring compounds and methods |
| 09/03/2009 | US20090221547 Immunosuppressant Compounds and Compositions |
| 09/03/2009 | DE102008012435A1 New quinazoline compounds are tyrosin-kinase inhibitors e.g. to treat cancer, hematologic or solid tumors, non-Hodgkin tumors or T-cell lymphoma; and for the modulation of the cell cycle, cell differentiation, apoptosis or angiogenesis |
| 09/03/2009 | CA2716898A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | CA2716109A1 Heteroaryl derivatives as cftr modulators |
| 09/02/2009 | EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same |
| 09/02/2009 | EP2094672A2 Arylsulfonamide compounds |
| 09/02/2009 | EP2094671A1 Heterobicyclic metalloprotease inhibitors |
| 09/02/2009 | EP2094660A2 Immunochemically equivalent hiv drug analogs |
| 09/02/2009 | EP2094645A1 2-hydroxy-1,3-diaminopropane derivatives |
| 09/02/2009 | EP2094272A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 09/02/2009 | EP2024338B1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments |
| 09/02/2009 | EP1937672B1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 09/02/2009 | EP1902037B1 2,4-diamino-pyrimidines used as aurora inhibitors |
| 09/02/2009 | CN101522643A Bicyclic heteroaromatic compounds |
| 09/02/2009 | CN101522642A Process for preparing 6-phen0xypyrimidin-4-ol derivatives in the presence of a quinuclidine or a n-methyl pyrrolidine derivative |
| 09/02/2009 | CN101522641A Process for synthesis of phenoxy diaminopyrimidine derivatives |
| 09/02/2009 | CN101522640A Pyrimidine compounds for combating pathogenic fungi and cancer |
| 09/02/2009 | CN101522639A Preparation of azoxystrobin |
| 09/02/2009 | CN101519378A Diaryl pyrimidyl guanidine and preparation method and pharmaceutical use of same |
| 09/02/2009 | CN101519377A Method for producing substituted dichloropyrimidine |
| 09/01/2009 | US7582765 Aryl aniline β2 adrenergic receptor agonists |
| 09/01/2009 | US7582759 Diastereomeric purification of rosuvastatin |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | US7582645 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582643 Asthma therapy; antiallergens; antiinflammatory agents |
| 09/01/2009 | US7582641 Gyrase inhibitors and uses thereof |